SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-05-000017
Filing Date
2005-08-15
Accepted
2005-08-15 16:49:53
Documents
2
Period of Report
2005-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR 2Q 2005 EARNINGS RELEASE earnings2q05.htm 8-K 20707
2 DOR EARNINGS PRESS RELEASE 2Q-2005 earnings.htm EX-99.1 34220
  Complete submission text file 0000812796-05-000017.txt   56648
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 051027425
SIC: 2834 Pharmaceutical Preparations